HiGamm-Equi (Equine IgG)

For Veterinary Use, Not Intended for Humans

500 ml, 1000 ml

For intravenous use in the treatment of failure of passive transfer in the equine neonate at a dose of 20ml/kg of body weight. The diagnosis of failure of passive transfer should be established from a blood sample taken 18 hours after birth.

KEEP FROZEN AT ≤-15C UNTIL USE. Thaw quickly in warm water not exceeding 110F. DO NOT MICROWAVE. Administer as soon as possible after thawing to body temperature by filtered intravenous infusion at a rate of 20ml/kg (shock bolus) over a period of 15-20 minutes. Do not mix with other products, except as specified on the label.

In case of a reaction, marked most often by tenesmus and hyperventilation, slow the speed of administration. If this does not abate the signs, stop administration until signs abate and continue at a slower rate. If signs persist, suspend administration and treat with histamine blockers and anti-inflammatory agents. Discard any unused portion.

Each single dose bag contains plasma as a source of equine IgG with sodium citrate as an anticoagulant derived from healthy horses with Aa and Ca r.b.c. antigens and no r.b.c antibodies. All donor horses are negative for EVA, Dourine, Brucellosis, Piroplasmosis and Glanders. This product has tested free of Equine Parvovirus-Hepatitis and Equine Infectious Anemia. There is no preservative added.

CAUTION: Anaphylaxis may occur. This product has not been processed by heating or treating with ionizing radiation and may be capable of spreading disease. The use of equine serum and plasma products has been associated with hepatitis (Theiler’s Disease). This product has not been tested in pregnant animals. In case of human exposure, contact a physician.

US Vet. Lic. No. 318, Product Code No. 3607.01

LAKE IMMUNOGENICS, INC. ONTARIO, NY 14519

1-800-648-9990

CPN: 1119001.11